CS logo
small CS logo
LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie

Graz, Austria
Hospital in Graz
Auenbruggerpl. 15, 8036 Graz

About LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Genentech, Inc.
1
Total Rows: 2

Clinical Trials at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie


During the past decade, LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111122110011000000110011Started TrialsCompleted Trails2015201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
2014-11-12
2017-03-13
Completed
334
A Study of Atezolizumab in Advanced Solid Tumors
2015-07-16
2020-07-28
Completed
474
A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)
2016-11-16
2024-12-18
Active, not recruiting
629
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen
2017-01-10
2022-12-20
Completed
772
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
2017-06-30
2023-12-31
Active, not recruiting
1,101
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
2018-07-10
2024-06-09
Active, not recruiting
790

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie" #1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 8Hoffmann-La Roche: 8Genentech, Inc.: 1Genentech, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAustrian Breast andColorectal CancerGroup: 1Austrian Breast andColorectal CancerGroup: 1Breast International Group: 1Breast International Group: 1Exelixis: 1Exelixis: 1Foundation Medicine, Inc.: 1Foundation Medicine, Inc.: 1SOLTI Breast CancerResearch Group: 1SOLTI Breast CancerResearch Group: 1

Clinical Trials Conditions at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie


According to Clinical.Site data, the most researched conditions in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie" are "Breast Cancer" (3 trials), "Breast Neoplasms" (1 trials), "Cancer of Unknown Primary Site" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie" in a lesser frequency.

Clinical Trials Intervention Types at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie


Most popular intervention types in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Docetaxel" (2 trials), "Ipatasertib" (2 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie


The vast majority of trials in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie" are 6 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Clinical Trials Status at LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie


Currently, there are NaN active trials in "LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Active, not recruiting: 4Active, not recruiting: 4